WaferGen Reports Sales Spike, Trimmed Loss in Q2 | GenomeWeb

NEW YORK (GenomeWeb) – WaferGen Biosystems reported after the close of the market Thursday that its second quarter revenues rose over 600 percent and that its net loss was down 38 percent compared with the year-ago period.

The genetic analysis products maker reported total revenues of $1.7 million for the three months ended June 30, up from $246,248 in Q2 2013. The firm's product revenue was $1.7 million versus $121,248 year over year, while its license and royalty revenue remained flat for the quarter at $125,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.